内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Puryear Pamela, 董事. Director active across 4 companies, notably Nextgen Healthcare, INC.. Aggregated, 15 disclosures have been logged. History available since 2 November 2021. The latest transaction was filed on 22 September 2025 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Puryear Pamela
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
18,345 股@ US$26.90100.0% 占其流量Common StockSEC:0001840088-25-000003:0
4,230 股0Common StockSEC:0000093389-25-000042:0
7,745 股Common StockSEC:0001562180-25-002530:0
7,847 股0Common StockSEC:0001562180-25-002375:0
3,034 股0Common StockSEC:0000093389-24-000002:0
31,028 股Common StockSEC:0000950170-23-062994:0
10,086 股@ US$16.36100.0% 占其流量Common StockSEC:0001209191-23-047038:0
2,755 股0Common StockSEC:0000093389-23-000010:0
5,980 股0Common StockSEC:0001562180-23-002330:0
9,483 股0Common StockSEC:0001209191-22-046678:0
7,333 股0Ordinary ShareSEC:0001852117-22-000202:0
2,650 股0Common StockSEC:0001567619-22-011334:0
4,620 股0Common StockSEC:0000905729-22-000079:0
897 股0Common StockSEC:0001567619-21-022172:0
11,459 股0Common StockSEC:0001209191-21-062934:0
About Puryear Pamela
Puryear Pamela is Administrateur and has 15 filings in total. Among the sampled recent filings, they cover the period from 2021-11-04 to 2025-09-22, with EUR 0 of purchases and EUR 418166 of sales, the most recent being a sale of SpartanNash Co on 2025-09-22 for EUR 418165.5158444943.